Krensavage Asset Management »

Eagle Pharmaceuticals shares owned by Krensavage Asset Management

Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by Krensavage Asset Management from 13F filings

Historical chart of Krensavage Asset Management investment in Eagle Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eagle Pharmaceuticals held by Krensavage Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eagle Pharmaceuticals by Krensavage Asset Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.8M 113k 15.77
2023-06-30 $2.2M 113k 19.44
2023-03-31 $3.2M 114k 28.37
2022-12-31 $3.4M 115k 29.23
2022-09-30 $3.2M 121k 26.42
2022-06-30 $5.4M 121k 44.43
2022-03-31 $5.7M 115k 49.49
2021-12-31 $5.4M 107k 50.92
2021-09-30 $6.0M 108k 55.78
2021-06-30 $3.0M 71k 42.79

More positions owned by Krensavage Asset Management

United Therapeutics Corporation (UTHR)
Enanta Pharmaceuticals (ENTA)
Jazz Pharmaceuticals (JAZZ)
BioMarin Pharmaceutical (BMRN)
Exelixis (EXEL)
Supernus Pharmaceuticals (SUPN)
Sanofi-Aventis SA (SNY)
Avadel Pharmaceuticals (AVDL)
GSK (GSK)
Cardinal Health (CAH)
Indivior (INDV)
Biontech Se (BNTX)
Alkermes (ALKS)
Vanda Pharmaceuticals (VNDA)
Regeneron Pharmaceuticals (REGN)

View all positions for Krensavage Asset Management

Top funds holding Eagle Pharmaceuticals

Stanley-Laman
Archer Investment Corp

View all funds holding Eagle Pharmaceuticals